Concepedia

Andrew Price

AP

Statistics

Publications

4

Citations

592

H-Index

4

Active since

2001

Affiliations

Novartis (United States)(Current)

Andrew Price is an author at Novartis (United States) specializing in life sciences, immunology, and autologous car t-cell therapy.

ORCID

Publications per year

2001–2023

4

Publications

4

STIMULATION OF TNF-α RELEASE IN MONOCYTES BY HONEY

Alex Tonks, R.A. Cooper, Andrew Price et al. · Cytokine · 2001 · 237 citations

, , +6

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells

Nathan Singh, Noelle V. Frey, Boris Engels et al. · Nature Medicine · 2021 · 202 citations · Full text

, , +12

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

Michael Dickinson, Pere Barba, Ulrich Jäger et al. · Cancer Discovery · 2023 · 121 citations · Full text

, , +17

Preservation of T-Cell Stemness with a Novel Expansionless CAR-T Manufacturing Process, Which Reduces Manufacturing Time to Less Than Two Days, Drives Enhanced CAR-T Cell Efficacy

Boris Engels, Xu Zhu, Jennifer Yang et al. · Blood · 2021 · 32 citations

, , +17

1–4 of 4